Randomized, Double-Blind Placebo-Controlled Multi-Center Proof-of-Concept Study to Assess the Efficacy of AIN457 in Patients With Psoriatic Arthritis

Trial Profile

Randomized, Double-Blind Placebo-Controlled Multi-Center Proof-of-Concept Study to Assess the Efficacy of AIN457 in Patients With Psoriatic Arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Nov 2015

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Psoriatic arthritis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 09 Nov 2011 Results for the parent study presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
    • 02 Feb 2011 New source identified and integrated (United Kingdom Clinical Research Network).
    • 07 Apr 2009 Actual initiation date (Mar 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top